Search results for: 'crm ad pace clinical'

This study maps the customer behaviour and expectations from CRM solution implemented in Malaysian enterprises. Further the study also assesses the most suitable vendor fulfilling customer criteria and challenges, alongwith a top of the mind vendor analysis in Malaysia CRM market.

This research service presents a comprehensive overview of the North American mobile CRM market with in-depth market analysis of its two major segments, namely mobile sales force automation (SFA) and mobile field service management (FSM). This research service discusses the major industry challenges, market drivers and restraints, and trends that a...

The evolution in autonomy and increase in the adoption of driver assistance systems have generated a need to sense and perceive the surrounding environment of a vehicle entirely and accurately. The fusion of forward-looking sensor data has given OEMs and Tier-I suppliers opportunities to offer multiple ADAS applications at low costs, while providin...

Major automotive OEMs globally are now incorporating active safety and automated vehicle technologies in their future vehicle line-ups to enhance safety and driver comfort. To gauge the suitability of each technology, continuous testing and validation is a must. Based on supportive legislation, several regions across the globe have been identified ...

This report provides a concise graphic snapshot of the changing face of the products and services which comprise the Customer Relationship Management market for U.S. pharmaceutical organizations from 2004-2007. It includes a breakdown of sub-markets, including SFA software, marketing/back office analytics software, and call center services. Each su...

09 May 2019  |  North America  |  Market Outlook

Global Autonomous Driving (AD) Industry Outlook, 2019

1 in 4 Cars Sold (18 Million) Globally is Expected to be Automated (L3 and Above) by 2030, with L4 Driving the Growth of Ownership

Infographics

×

Key Issues Addressed

The autonomous driving industry is evolving at a rapid pace on various fronts such as advancements in technology as well as emergence of new business models. Traditionally, most major OEMs and Tier I suppliers have strived to explore the benefits of developing applications focused on the convergence of the three technology pillars: Connected, Auton...

The immunoassay and clinical chemistry market is the highest share contributor for the total in vitro diagnostics (IVD) market. Globally valued at $28.7 billion in 2019, this market segment contributes 37.6% of the total IVD market of $76.3 billion. Within the high-medium to low analyzer segment, there are over 40 companies globally. Of these, 14 c...

In the last decade, nanomedicine and nanotechnology have helped unlock revolutionary therapeutic potential that has positively impacted healthcare. Among the different nanotechnology-based innovations, lipid-based nanoparticles such as liposomes and lipid nanoparticles (LNPs) show great promise across multiple therapies. Although the Food and Drug ...

This research service analyzes the market for clinical laboratory analyzers within the United States. The United States market was divided into the clinical chemistry, immunoassay, integrated, hematology, hemostasis, and blood gas analyzer market segments. Each segment of this service covers market drivers, market restraints, competitive structur...